Senior insider sale
Chief Executive Officer at BEONE MEDICINES LTD. — senior position signals high conviction
$193.12M
637.33K shares
OYLER JOHN plans to sell 637.33K shares of BEONE MEDICINES LTD. valued at approximately $193.12M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Exercise of Stock Options
Cash
Restricted Stock Units
N/A
Previously Exercised Stock Options
Cash
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/14/2026 | Exercise of Stock Options Cash | 425.59K | — |
6/5/2026 | Restricted Stock Units N/A | 12.26K | — |
3/3/2025 | Previously Exercised Stock Options Cash | 75.72K | — |
| Total | 513.57K | ||
Completed
Units to sell
48.52K
Market value
$14.77M
Units to sell
37.72K
Market value
$11.48M
Units to sell
11.82K
Market value
$3.53M
Units to sell
11.70K
Market value
$3.49M
Units to sell
3.41K
Market value
$933.6K
Units to sell
3.69K
Market value
$980.7K
Units to sell
1.95K
Market value
$501.4K
Units to sell
4.94K
Market value
$1.34M
Planned — Approximate Date
Units to sell
513.57K
Market value
$156.11M
Units
637.33K
Value
$193.12M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/13/2026 | 48.52K | $14.77M | — | Completed |
7/13/2026 | 37.72K | $11.48M | — | Completed |
7/10/2026 | 11.82K | $3.53M | — | Completed |
7/10/2026 | 11.70K | $3.49M | — | Completed |
6/23/2026 | 3.41K | $933.6K | — | Completed |
6/16/2026 | 3.69K | $980.7K | — | Completed |
6/11/2026 | 1.95K | $501.4K | — | Completed |
6/8/2026 | 4.94K | $1.34M | — | Completed |
| Planned — Approximate Date | ||||
7/14/2026 | 513.57K | $156.11M | NASDAQ | Planned |
| Total | 637.33K | $193.12M | ||